Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Recruiting · NCT07281417 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma | Sinonasal Squamous Cell Carcinoma; Stage III Sinonasal Cancer AJCC v8; Stage IVA Sinonasal Cancer AJCC v8; Stage IVB Sinonasal Cancer AJCC v8 | Recruiting | Phase 2 | 2026-10-05 | NCT07281417 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
18 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.